Valérie Martin

Title: Valérie Martin: Innovator in Therapeutic Compounds

Introduction

Valérie Martin is a prominent inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic compounds. With a total of 2 patents, his work focuses on innovative solutions for treating various diseases.

Latest Patents

Valérie Martin's latest patents include groundbreaking inventions. The first patent is titled "Pyrazolonaphthyridinone derivatives as MetAP2 inhibitors." This invention relates to pyrazolonaphthyridinone derivatives of formula (I), their preparation, and their therapeutic use as selective inhibitors of type 2 methionine aminopeptidase (hMETAP2). The second patent is "Pyridino-pyridinone derivatives, preparation and therapeutic use thereof." This invention concerns derivatives of pyridino-pyridinones, their preparation, and their use as inhibitors of kinase activity of receptors for PDGF (platelet-derived growth factors) ligands, and optionally of receptors for the FLT3 (fms-like tyrosine kinase receptor) ligand receptors. These compounds are suitable as therapeutics for the treatment of various proliferative diseases.

Career Highlights

Valérie Martin is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on the development of innovative therapeutic solutions. His expertise in medicinal chemistry has positioned him as a key player in the field.

Collaborations

Valérie has collaborated with notable colleagues, including Gilbert Lassalle and Gary McCort. These collaborations have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Valérie Martin's contributions to the field of medicinal chemistry through his innovative patents demonstrate his commitment to advancing therapeutic solutions. His work continues to impact the treatment of various diseases, showcasing the importance of innovation in healthcare.